We Committed To
Providing High Quality

More details about the test kitGO
Hangzhou Immuno Biotech Co., Ltd. Will focus on the human medical diagnostic field and mainly cover the following directions:rapid tests for vector-borne diseases(VBDs),rapid tests for sexually transmitted diseases (STDs),rapid tests for respiratory system diseases and rapid teses for digestive system diseases. Besides, with strong R&D capability,we would pay more attention to the diagnosis of neglected tropical diseases (NTDs).
How to test?

Main Products We Supply

IMMUNOBIO R&D and produce high quality COVID-19 test kits, and also provide uncut sheet and Proteins.

About us

Hangzhou Immuno Biotech Co.,Ltd is the original organization in Immuno Group. The team of Hangzhou Immuno Biotech has developed a series of proteins and rapid test kits for the in vitro diagnostic industry in early stage. Gradually, IMMUNO was well known as a good R&D partner and good supplier of veterinary rapid test products.

view more
  • >50

    With more than 50 patents, which are gradually being translated into products and services for customers

  • > 15%

    More than 15% of annual sales are invested in product research and development

  • >100

    In the past year, we have provided technical support and services to more than 100 companies in the same industry

  • > 50%

    In recent years, the company's annual sales growth rate is more than 50%, more and more customers choose us

latest news & blogs

view more
  • Immunobio At 2023 Beijing International Life and Health Industy Expo

    Immunobio At 2023 Beijing International Life and Health Industy Expo July 13, 2023Booth No.:3206Exhibition Venue: China International Exhibition Center, 6 East Beisanhuan Road, Chaoyang District, Beij
    read more
  • Monkeypox antigen test is available

    On August 15, 2022, IMMUNOBIO’s Monkeypox antigen rapid test has been successfully developed.This product is still using IMMUNO BIO’s strong technology, colloidal gold lateral immunochromatography.Res
    read more
  • Monkeypox rapid test is available

    On May 27, 2022,IMMUNOBIO laboratory successfully developed monkeypox recombinant antigen. As soon as the raw material products were launched, orders were received from various experiments across the
    read more

Leave Your Message